ENG/中
老虎證券
行情
交易
收費
下載
優惠與活動
幫助
TigerAI
學堂
期權訓練營
投資學堂
機構
財富及資產管理人
自營交易機構
介紹經紀商
三方服務商
股權激勵
關於
關於我們
媒體報道
獎項與榮譽
登入
立即註冊
Toggle
美股
詳情
本頁面由Tiger Trade Technology Pte. Ltd.提供服務
生物科技指數ETF-iShares Nasdaq
216.40
+3.87
1.82%
盤後：
216.00
-0.4000
-0.18%
19:59 EDT
成交量：
146.62萬
成交額：
3.17億
市值：
108.85億
市盈率：
34.28
高：
217.12
開：
213.40
低：
213.22
收：
212.53
52周最高：
217.12
52周最低：
137.09
股本：
5,030.00萬
流通股本：
5,030.00萬
量比：
0.69
換手率：
2.91%
股息：
0.40
股息率：
0.19%
每股收益(TTM):
6.31
每股收益(LYR):
-1.4940
淨資產收益率：
24.54%
總資產收益率：
0.10%
市淨率：
1.34
市盈率(LYR):
-144.85
資料載入中...
總覽
公司
新聞資訊
公告
吉利德科學於2026年8月4日公布了2026年第二季度財務業績。總收入按年增長10%達到78億美元主要得益於不包括Vek
智通财经
·
08/05
安進高管表示，預計第三季度運營支出將出現顯著的按月增長。
智通财经
·
08/05
安進高管重申：2026年資本支出預計約26億美元，用於擴大產能，含Maritide上市準備
美股速递
·
08/05
安進高管：Q2資本支出達5億美元，聚焦全美製造基地投資——電話會議紀要
美股速递
·
08/05
安進高管在電話會議上表示，第二季度資本支出達5億美元，主要受美國各地生產基地投資推動。
智通财经
·
08/05
吉利德高管在電話會議中宣佈：全年HIV業務增長預期上調至9%-10%，此前指引為8%
美股速递
·
08/05
吉利德高管：距FDA PDUFA日期僅剩五個月，Anito-Cel細胞療法上市籌備工作已全面啓動
美股速递
·
08/05
吉利德科學第二季度調整後每股收益-6.75美元，高於IBES預估-7.24美元
投资观察
·
08/05
安進(AMGN)股票8月4日收盤上漲3.03%：關鍵驅動因素揭曉
TradingKey中文
·
08/05
吉利德科學：季度調整後每股虧損6.75美元，反映近期收購帶來的每股9.08美元知識產權研發及税務支出
美股速递
·
08/05
安進第二季度銷售額增長9%，利潤超出華爾街預期
路透中文
·
08/05
吉利德第二季度銷售額增長8%，超出華爾街預期
路透中文
·
08/05
前瞻：安進股價在財報公布前走高
路透中文
·
08/05
Vertex 擴大領導團隊，為下一階段增長注入強勁動力
投资观察
·
08/04
重點關注個股：Palantir、SpaceX、滙豐控股
投资观察
·
08/04
非阿片止痛藥新鋭Latigo(LTGO.US)IPO擬最高募資2.88億美元，Nav1.8抑制劑劍指福泰製藥(VRTX.US)百億市場
智通财经
·
08/04
福泰製藥重申2026年全年指引：GAAP與非GAAP研發、AI研發及銷售管理費用預期不變
美股速递
·
08/04
福泰製藥：基於現行關税法規，2026年指引中關税成本影響依然微乎其微
美股速递
·
08/04
Vertex憑藉囊性纖維化藥物的強勁表現上調年度營收預期
路透中文
·
08/04
加州最高法院在「創新義務」案中裁定吉利德勝訴
路透中文
·
08/04
更多
{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎證券香港 | 輕鬆買賣美股港股A股/美債/ETF/Crypto/期權期貨","description":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","keywords":"老虎證券,老虎證券開戶,老虎證券香港,老虎證券投資,老虎證券美股,老虎證券登錄,證券開戶,證券公司開戶,股票開戶,香港證券公司,香港證券,證券公司,美股投資平台,小額投資理財,投資app,投資平台,股票買賣,買賣股票平台,炒股app,證券app,新手投資","social":{"ogDescription":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrdive.com/hant/stock/IBB/news?page=4"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"IBB","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IBB\",,,,,undefined,":{"symbol":"IBB","market":"US","secType":"STK","nameCN":"生物科技指數ETF-iShares Nasdaq","latestPrice":216.4,"timestamp":1787688000000,"preClose":212.53,"halted":0,"volume":1466169,"hourTrading":{"tag":"盘后","latestPrice":216,"preClose":216.4,"latestTime":"19:59 EDT","volume":19054,"amount":4123254.049,"timestamp":1787702394520,"change":-0.4,"changeRate":-0.001848,"amplitude":0.001848},"delay":0,"changeRate":0.018209193996141744,"floatShares":50300000,"shares":50300000,"eps":6.311863,"marketStatus":"已收盤","change":3.87,"latestTime":"08-25 16:00:00 EDT","open":213.4,"high":217.12,"low":213.22,"amount":316799197.11812997,"amplitude":0.01835,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":6.311863,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1787731200000},"marketStatusCode":5,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":212.53,"sharesOutstanding":49450000,"nav":212.515646,"aum":10647033864.6,"dividendRate":0.001866,"bidAskSpread":0.000376,"preHourTrading":{"tag":"盘前","latestPrice":213.19,"preClose":212.53,"latestTime":"09:29 EDT","volume":272,"amount":58020.02352,"timestamp":1787664595037,"change":0.66,"changeRate":0.003105,"amplitude":0.007293},"postHourTrading":{"tag":"盘后","latestPrice":216,"preClose":216.4,"latestTime":"19:59 EDT","volume":19054,"amount":4123254.049,"timestamp":1787702394520,"change":-0.4,"changeRate":-0.001848,"amplitude":0.001848},"volumeRatio":0.68846,"impliedVol":0.2594,"impliedVolPercentile":0.8566},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IBB\",,,,,undefined,":{"symbol":"IBB","floatShares":50300000,"roa":"0.10%","roe":"24.54%","lyrEps":-1.493977,"volumeRatio":0.68846,"shares":50300000,"dividePrice":0.4038,"high":217.12,"amplitude":0.01835,"preClose":212.53,"low":213.22,"week52Low":137.09,"pbRate":"1.34","psRate":"261.88","week52High":217.12,"institutionHeld":0,"latestPrice":216.4,"eps":6.311863,"divideRate":0.001866,"volume":1466169,"delay":0,"ttmEps":6.311863,"open":213.4,"prevYearClose":168.77,"prevWeekClose":213.56,"prevMonthClose":186.41,"prevQuarterClose":190.19,"fiveDayClose":203.56,"twentyDayClose":190.52,"sixtyDayClose":172.18},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/IBB\",params:#limit:5,,,undefined,":[{"date":"2026-06-15","symbol":"IBB","amount":0.023774,"announcedDate":"2026-06-12","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-15","defaultRemindTime":1781530200000,"name":"生物科技指数ETF-iShares Nasdaq","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-18","payableDate":"2026-06-15","currency":"USD","dateTimestamp":1781496000000,"payDate":"2026-06-18"},{"date":"2026-03-17","symbol":"IBB","amount":0.121818,"announcedDate":"2026-03-16","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-17","defaultRemindTime":1773754200000,"name":"生物科技指数ETF-iShares Nasdaq","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-20","payableDate":"2026-03-17","currency":"USD","dateTimestamp":1773720000000,"payDate":"2026-03-20"},{"date":"2025-12-16","symbol":"IBB","amount":0.183099,"announcedDate":"2025-12-15","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-16","defaultRemindTime":1765895400000,"name":"生物科技指数ETF-iShares Nasdaq","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-19","payableDate":"2025-12-16","currency":"USD","dateTimestamp":1765861200000,"payDate":"2025-12-19"},{"date":"2025-09-16","symbol":"IBB","amount":0.082843,"announcedDate":"2025-09-15","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-16","defaultRemindTime":1758029400000,"name":"生物科技指数ETF-iShares Nasdaq","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-19","payableDate":"2025-09-16","currency":"USD","dateTimestamp":1757995200000,"payDate":"2025-09-19"},{"date":"2025-03-18","symbol":"IBB","amount":0.121169,"announcedDate":"2025-03-17","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-18","defaultRemindTime":1742304600000,"name":"生物科技指数ETF-iShares Nasdaq","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-03-21","payableDate":"2025-03-18","currency":"USD","dateTimestamp":1742270400000,"payDate":"2025-03-21"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"IBB\",market:\"US\",,,undefined,":[{"executeDate":"2016-09-26","recordDate":"2016-09-28","paymentDate":"2016-09-30","value":0.0858219,"currency":"USD"},{"executeDate":"2016-12-22","recordDate":"2016-12-27","paymentDate":"2016-12-29","value":0.091903,"currency":"USD"},{"executeDate":"2017-03-24","recordDate":"2017-03-28","paymentDate":"2017-03-30","value":0.29898,"currency":"USD"},{"executeDate":"2017-06-27","recordDate":"2017-06-29","paymentDate":"2017-06-30","value":0.176803,"currency":"USD"},{"executeDate":"2017-09-26","recordDate":"2017-09-27","paymentDate":"2017-09-29","value":0.118654,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"IBB\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"IBB\",pageSize:20,pageCount:4,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2657679605","title":"吉利德科學於2026年8月4日公布了2026年第二季度財務業績。總收入按年增長10%達到78億美元主要得益於不包括Vek","url":"https://stock-news.laohu8.com/highlight/detail?id=2657679605","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657679605?lang=zh_tw&edition=fundamental","pubTime":"2026-08-05 05:10","pubTimestamp":1785877839,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["IBBQ","IE00B19Z3B42.SGD","IE00B7SZLL34.SGD","BK4585","LU0889565916.HKD","LU1571399168.USD","BK4583","LU0965509283.SGD","GILD","LU2324357040.USD","LU1023059063.AUD","LU1430594728.SGD","LU0122379950.USD","MEDI","LU1778281490.HKD","LU0058720904.USD","BIB","LU0114720955.EUR","LU0861579265.USD","IE0002270589.USD","LU0965509010.AUD","SG9999015978.USD","LU1839511570.USD","LU0109394709.USD","LU0234570918.USD","TMED","LU1674673428.USD","LU0823416689.USD","LU1066051498.USD","SG9999015986.USD","IE00BKVL7J92.USD","LU2468319806.SGD","IE00B19Z3581.USD","BK4550","BBH","BMED","BK4568","LU2089984988.USD","SG9999015952.SGD","LU1934455277.USD","IE00BZ1G4Q59.USD","LU0882574055.USD","IBB","LU1037948541.HKD","LU0965508806.USD","LU1057294990.SGD","LU2087621335.USD","LU1061106388.HKD","TBXU","IE00BSNM7G36.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657376567","title":"安進高管表示，預計第三季度運營支出將出現顯著的按月增長。","url":"https://stock-news.laohu8.com/highlight/detail?id=2657376567","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657376567?lang=zh_tw&edition=fundamental","pubTime":"2026-08-05 05:02","pubTimestamp":1785877379,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["IE00B4R5TH58.HKD","BK4533","LU1983299246.USD","LU1057294990.SGD","BK4585","LU1571399168.USD","LU2112291526.USD","BK4534","LU0109394709.USD","BIB","SG9999001440.SGD","LU0289739699.SGD","IBBQ","BK4566","LU0320765992.SGD","TBXU","BBH","LU2242646821.SGD","IE00BJT1NW94.SGD","LU2089984988.USD","IE00B2B36J28.USD","LU1061106388.HKD","IE00BJJMRZ35.SGD","IE0009355771.USD","BK4581","IE00BFTCPJ56.SGD","PJP","AMGN","BK4599","LU0058720904.USD","BK4588","LU0889565916.HKD","IE0002141913.USD","LU1023059063.AUD","PBE","BK4139","LU0122379950.USD","LU2242652126.USD","LU2468319806.SGD","LU0868494617.USD","IBB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1191538261","title":"安進高管重申：2026年資本支出預計約26億美元，用於擴大產能，含Maritide上市準備","url":"https://stock-news.laohu8.com/highlight/detail?id=1191538261","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1191538261?lang=zh_tw&edition=fundamental","pubTime":"2026-08-05 05:01","pubTimestamp":1785877307,"startTime":"0","endTime":"0","summary":"安进高管最新表态，公司将继续维持2026年资本支出约26亿美元的预期。这笔资金的核心用途，正是为了扩大制造产能——其中，Maritide的上市准备工作尤为关键。\n26亿美元，一个庞大的数字，却承载着安进对未来市场的信心与布局。产能扩张，尤其是为Maritide的上市铺路，成为了这笔巨额支出的重中之重。这不仅仅是一次简单的投资，更是对战略产品线的全力押注。\n高管在发言中强调，该预期反映了公司对生产能力持续优化的坚定承诺。从长远来看，扩大制造规模不仅是为了满足现有产品的需求，更是为了确保Maritide等关键新药能够顺利推向市场。这一举措，无疑将为公司在竞争激烈的生物制药领域构筑更坚实的护城河。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IBBQ","AMGN","PBE","LU0289739699.SGD","BK4585","LU0889565916.HKD","LU1571399168.USD","BK4581","LU0868494617.USD","LU0320765992.SGD","LU1023059063.AUD","IE0009355771.USD","IE00BJJMRZ35.SGD","IE00BFTCPJ56.SGD","SG9999001440.SGD","LU0122379950.USD","IE0002141913.USD","BK4139","BK4588","LU0058720904.USD","BIB","LU2112291526.USD","BK4533","LU0109394709.USD","IE00B4R5TH58.HKD","LU2468319806.SGD","LU1983299246.USD","IE00B2B36J28.USD","BK4599","BK4566","BBH","LU2089984988.USD","LU2242646821.SGD","BK4534","IBB","PJP","LU1061106388.HKD","TBXU","LU1057294990.SGD","IE00BJT1NW94.SGD","LU2242652126.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1128189819","title":"安進高管：Q2資本支出達5億美元，聚焦全美製造基地投資——電話會議紀要","url":"https://stock-news.laohu8.com/highlight/detail?id=1128189819","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1128189819?lang=zh_tw&edition=fundamental","pubTime":"2026-08-05 05:01","pubTimestamp":1785877299,"startTime":"0","endTime":"0","summary":"安进（Amgen）公司高管在电话会议中透露，第二季度资本支出高达5亿美元。这笔巨额投入的核心驱动力，正是该公司在全美多个制造基地进行的战略布局。投资浪潮席卷了美国的各个生产设施，从而推动了整体资本开支的显著增长。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4566","BK4588","BK4139","IE00B2B36J28.USD","BK4581","PJP","IE0002141913.USD","IE00BJJMRZ35.SGD","BK4534","LU0868494617.USD","LU1061106388.HKD","IE0009355771.USD","LU2089984988.USD","LU1983299246.USD","LU2242646821.SGD","SG9999001440.SGD","LU0109394709.USD","LU1571399168.USD","IE00BJT1NW94.SGD","LU0058720904.USD","LU2242652126.USD","LU0889565916.HKD","BK4533","LU2468319806.SGD","LU1057294990.SGD","LU0320765992.SGD","LU1023059063.AUD","BK4599","LU0289739699.SGD","BK4585","LU2112291526.USD","BIB","IBBQ","LU0122379950.USD","IE00BFTCPJ56.SGD","AMGN","IE00B4R5TH58.HKD","TBXU","BBH","PBE","IBB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657562205","title":"安進高管在電話會議上表示，第二季度資本支出達5億美元，主要受美國各地生產基地投資推動。","url":"https://stock-news.laohu8.com/highlight/detail?id=2657562205","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657562205?lang=zh_tw&edition=fundamental","pubTime":"2026-08-05 04:59","pubTimestamp":1785877188,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["DUSL","LU2468319806.SGD","IE00BJT1NW94.SGD","LU0289739699.SGD","IBB","LU1057294990.SGD","LU2242646821.SGD","TBXU","LU1571399168.USD","BK4534","SG9999001440.SGD","IE00B2B36J28.USD","IE00BJJMRZ35.SGD","LU0320765992.SGD","LU0889565916.HKD","IE0002141913.USD","LU2242652126.USD","BK4599","BIB","LU0868494617.USD","IE00B4R5TH58.HKD","IE0009355771.USD","LU2089984988.USD","IE00BFTCPJ56.SGD","BBH","BK4566","BK4581","AMGN","LU1983299246.USD","PJP","PBE","BK4585","LU2112291526.USD","FXR","LU0058720904.USD","IBBQ","BK4533","LU1061106388.HKD","BK4139","LU1023059063.AUD","BK4588","LU0109394709.USD","LU0122379950.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1135051692","title":"吉利德高管在電話會議中宣佈：全年HIV業務增長預期上調至9%-10%，此前指引為8%","url":"https://stock-news.laohu8.com/highlight/detail?id=1135051692","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1135051692?lang=zh_tw&edition=fundamental","pubTime":"2026-08-05 04:42","pubTimestamp":1785876147,"startTime":"0","endTime":"0","summary":"吉利德（Gilead Sciences）高管在电话会议上透露，公司已将全年HIV业务增长预期上调至9%至10%的区间。这一调整较此前8%的增长指引显著提升，展现了公司对该业务领域强劲势头的信心。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999015978.USD","LU2324357040.USD","BK4588","SG9999015952.SGD","LU1839511570.USD","BMED","LU1430594728.SGD","IBBQ","BBH","IE0002270589.USD","IE00B7SZLL34.SGD","LU0965509010.AUD","IE00B19Z3581.USD","LU0234570918.USD","GILD","LU0823416689.USD","SG9999015986.USD","LU0122379950.USD","LU2112291526.USD","SG9999015945.SGD","LU0882574055.USD","IE00B19Z3B42.SGD","IE00BSNM7G36.USD","LU1037948541.HKD","BK4578","LU0965509283.SGD","LU1778281490.HKD","LU0058720904.USD","LU0889565916.HKD","LU0289739699.SGD","LU0965508806.USD","LU2087621335.USD","BK4583","BK4550","LU2089984988.USD","TBXU","LU1061106388.HKD","BK4139","LU1934455863.HKD","IE00B3T34201.USD","LU1674673691.USD","LU0109394709.USD","IE00BKVL7J92.USD","IBB","LU2468319806.SGD","BK4532","MEDI","LU1066051498.USD","LU1057294990.SGD","BIB","LU1934455277.USD","BK4566","LU1571399168.USD","IE00BZ1G4Q59.USD","LU0320765992.SGD","LU1037948897.HKD","LU1674673428.USD","LU0965509101.SGD","LU1066053197.SGD","LU1934455194.USD","LU0114720955.EUR","LU1585245621.USD","TMED","BK4585","LU0861579265.USD","LU1023059063.AUD","BK4568"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1145483121","title":"吉利德高管：距FDA PDUFA日期僅剩五個月，Anito-Cel細胞療法上市籌備工作已全面啓動","url":"https://stock-news.laohu8.com/highlight/detail?id=1145483121","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1145483121?lang=zh_tw&edition=fundamental","pubTime":"2026-08-05 04:42","pubTimestamp":1785876146,"startTime":"0","endTime":"0","summary":"吉利德科学（Gilead Sciences）高管透露，针对其重磅细胞疗法Anito-Cel的上市准备工作已全面铺开，目前距离美国食品药品监督管理局（FDA）设定的PDUFA目标日期仅剩五个月时间。这一消息源自公司近期召开的电话会议。\n在会议中，高管进一步强调，公司正紧锣密鼓地推进各项筹备事项，以确保一旦获批，该疗法能够迅速进入市场。Anito-Cel作为一种前沿的细胞治疗产品，被视为吉利德在肿瘤学领域布局的关键一环。随着最终审批日期的临近，市场对这款疗法的商业化前景给予高度关注，而吉利德方面则展现出对既定时间表与执行能力的充分信心。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BIB","IBBQ","IE00BSNM7G36.USD","LU1934455863.HKD","IE0002270589.USD","SG9999015952.SGD","LU2112291526.USD","TBXU","BK4566","LU1934455194.USD","LU0823416689.USD","LU2087621335.USD","LU1585245621.USD","LU0965508806.USD","LU0109394709.USD","IE00B19Z3581.USD","LU0889565916.HKD","LU0965509283.SGD","IE00BKVL7J92.USD","LU1023059063.AUD","LU0965509010.AUD","IE00B7SZLL34.SGD","SG9999015945.SGD","GILD","LU0861579265.USD","SG9999015986.USD","BBH","LU1674673428.USD","MEDI","BK4568","IE00B19Z3B42.SGD","BK4585","LU0882574055.USD","BK4139","BK4550","LU0965509101.SGD","LU2089984988.USD","LU1057294990.SGD","LU0289739699.SGD","BK4578","LU0320765992.SGD","LU1066051498.USD","LU2468319806.SGD","BK4532","LU0114720955.EUR","LU2324357040.USD","IE00BZ1G4Q59.USD","LU0122379950.USD","LU0058720904.USD","LU1066053197.SGD","BMED","LU1037948541.HKD","IBB","BK4588","LU1037948897.HKD","LU0234570918.USD","LU1571399168.USD","LU1839511570.USD","IE00B3T34201.USD","BK4583","LU1934455277.USD","LU1430594728.SGD","LU1778281490.HKD","SG9999015978.USD","LU1674673691.USD","LU1061106388.HKD","TMED"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1163992816","title":"吉利德科學第二季度調整後每股收益-6.75美元，高於IBES預估-7.24美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1163992816","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1163992816?lang=zh_tw&edition=fundamental","pubTime":"2026-08-05 04:17","pubTimestamp":1785874678,"startTime":"0","endTime":"0","summary":"8月4日，吉利德科学（Gilead Sciences）公布第二季度产品销售额达76.27亿美元。第二季度调整后每股收益为-6.75美元，优于IBES预估的-7.24美元。","market":"hk","thumbnail":"https://static.tigerbbs.com/9e7ba54e8539d48dd315975babea7852","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/9e7ba54e8539d48dd315975babea7852"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2468319806.SGD","LU0289739699.SGD","LU1057294990.SGD","IBB","LU1839511570.USD","BK4583","LU0114720955.EUR","SG9999015986.USD","TBXU","LU1571399168.USD","LU1934455194.USD","LU1430594728.SGD","TMED","LU1674673428.USD","BMED","LU0320765992.SGD","LU0889565916.HKD","SG9999015978.USD","LU0965509010.AUD","LU0965509101.SGD","BIB","LU1066051498.USD","LU2089984988.USD","IE00BSNM7G36.USD","BK4532","LU0882574055.USD","LU1934455863.HKD","LU1934455277.USD","LU0861579265.USD","IE00B19Z3B42.SGD","BBH","BK4566","LU0234570918.USD","BK4585","LU0122379950.USD","LU1037948541.HKD","LU2112291526.USD","LU0058720904.USD","IBBQ","BK4568","LU1061106388.HKD","MEDI","LU2087621335.USD","BK4139","IE0002270589.USD","IE00BKVL7J92.USD","LU0965509283.SGD","LU1023059063.AUD","IE00B7SZLL34.SGD","LU1037948897.HKD","BK4588","LU2324357040.USD","BK4550","LU0823416689.USD","GILD","LU1674673691.USD","LU0965508806.USD","LU1066053197.SGD","IE00B3T34201.USD","LU1585245621.USD","IE00BZ1G4Q59.USD","SG9999015952.SGD","LU0109394709.USD","IE00B19Z3581.USD","BK4578","LU1778281490.HKD","SG9999015945.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657627865","title":"安進(AMGN)股票8月4日收盤上漲3.03%：關鍵驅動因素揭曉","url":"https://stock-news.laohu8.com/highlight/detail?id=2657627865","media":"TradingKey中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657627865?lang=zh_tw&edition=fundamental","pubTime":"2026-08-05 04:16","pubTimestamp":1785874591,"startTime":"0","endTime":"0","summary":"• 安进公布的第二季度业绩超出了市场对营收和每股收益的共识预期。\n• 一款代谢健康候选药物的积极中期临床数据推动了其股价上涨。\n• 全年营收达到367.5亿美元，该公司的净利润排名位列第十。","market":"us","thumbnail":"https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/zh-hans/news/market-movers/262074405-market-movers-amgn-20260804","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2242652126.USD","LU1983299246.USD","PJP","IE0009355771.USD","LU2468319806.SGD","LU2089984988.USD","LU0320765992.SGD","BK4588","AMGN","IBB","TBXU","LU2242646821.SGD","LU0868494617.USD","PBE","BK4534","LU0058720904.USD","IBBQ","LU0109394709.USD","BK4581","BK4599","IE00BJJMRZ35.SGD","LU0889565916.HKD","LU1061106388.HKD","IE00BJT1NW94.SGD","BK4533","LU1571399168.USD","LU2112291526.USD","IE0002141913.USD","BIB","LU0289739699.SGD","LU1023059063.AUD","IE00B2B36J28.USD","BK4139","LU1057294990.SGD","SG9999001440.SGD","BBH","IE00B4R5TH58.HKD","IE00BFTCPJ56.SGD","LU0122379950.USD","BK4585","BK4566"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1108344321","title":"吉利德科學：季度調整後每股虧損6.75美元，反映近期收購帶來的每股9.08美元知識產權研發及税務支出","url":"https://stock-news.laohu8.com/highlight/detail?id=1108344321","media":"美股速递","labels":["dataReport","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1108344321?lang=zh_tw&edition=fundamental","pubTime":"2026-08-05 04:04","pubTimestamp":1785873878,"startTime":"0","endTime":"0","summary":"吉利德科学（Gilead Sciences）最新季度业绩揭晓。数据显示，公司调整后每股收益为-6.75美元。这一数字背后，折射出近期收购活动所产生的重大财务影响——具体而言，每股9.08美元的知识产权研发成本与税务费用被计入。这些支出，均与公司近期完成的收购交易紧密相关。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999015945.SGD","SG9999015952.SGD","BBH","BK4583","LU1571399168.USD","BK4532","LU1023059063.AUD","LU1674673691.USD","LU1037948541.HKD","LU1674673428.USD","LU1934455863.HKD","TBXU","BK4139","IE00B19Z3581.USD","LU0823416689.USD","LU0965509010.AUD","LU0882574055.USD","MEDI","LU1037948897.HKD","LU2112291526.USD","IE00B3T34201.USD","BK4550","LU0109394709.USD","LU1778281490.HKD","LU0889565916.HKD","LU0114720955.EUR","SG9999015986.USD","BK4588","LU0861579265.USD","LU0965509101.SGD","BK4568","LU1066051498.USD","LU1934455194.USD","LU1430594728.SGD","IBB","LU0122379950.USD","LU0965509283.SGD","BK4566","LU0234570918.USD","LU1839511570.USD","LU0965508806.USD","LU2089984988.USD","IE0002270589.USD","IE00B19Z3B42.SGD","BIB","LU2324357040.USD","GILD","BK4585","LU1061106388.HKD","SG9999015978.USD","LU0320765992.SGD","LU0058720904.USD","IE00BSNM7G36.USD","BMED","LU1066053197.SGD","IE00B7SZLL34.SGD","LU1057294990.SGD","IE00BZ1G4Q59.USD","LU0289739699.SGD","LU2087621335.USD","BK4578","LU1585245621.USD","IBBQ","LU2468319806.SGD","IE00BKVL7J92.USD","TMED","LU1934455277.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657569101","title":"安進第二季度銷售額增長9%，利潤超出華爾街預期","url":"https://stock-news.laohu8.com/highlight/detail?id=2657569101","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657569101?lang=zh_tw&edition=fundamental","pubTime":"2026-08-05 04:04","pubTimestamp":1785873843,"startTime":"0","endTime":"0","summary":"安进第二季度销售额增长9%，利润超出华尔街预期经调整的每股收益为6.29美元，超出分析师预期上调全年营收和利润预期安进公司停止开发第二款实验性减肥药AMG 513Deena Beasley路透8月4日-安进公司周二公布，受降胆固醇药物Repatha、骨质疏松药物Evenity以及罕见病药物需求推动，第二季度销售额增长9%。季度营收同比增长10%，达到101亿美元，超过了华尔街94.2亿美元的平均预期。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260804:nL4T4411XI:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4533","LU1023059063.AUD","BIB","BK4581","IE00BJJMRZ35.SGD","LU0109394709.USD","SG9999001440.SGD","PBE","BK4585","IBBQ","BK4588","IE00BJT1NW94.SGD","LU0320765992.SGD","IE0002141913.USD","LU2112291526.USD","LU1983299246.USD","LU1057294990.SGD","LU2242646821.SGD","LU0889565916.HKD","04332","BK4566","LU0289739699.SGD","LU2089984988.USD","IE0009355771.USD","LU0058720904.USD","LU0868494617.USD","BK4139","BK4534","LU1571399168.USD","LU2468319806.SGD","IE00BFTCPJ56.SGD","IE00B2B36J28.USD","BBH","IE00B4R5TH58.HKD","IBB","LU0122379950.USD","TBXU","LU2242652126.USD","LU1061106388.HKD","AMGN","PJP","BK4599"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657820569","title":"吉利德第二季度銷售額增長8%，超出華爾街預期","url":"https://stock-news.laohu8.com/highlight/detail?id=2657820569","media":"路透中文","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657820569?lang=zh_tw&edition=fundamental","pubTime":"2026-08-05 04:02","pubTimestamp":1785873759,"startTime":"0","endTime":"0","summary":"据LSEG数据显示，该公司总营收增长10%至78亿美元，超出华尔街预期的74亿美元。第二季度，吉利德公布经调整后每股亏损为6.75美元，而华尔街分析师平均预期为7.24美元。另一款较早上市的艾滋病口服药Descovy的季度销售额猛增48%，达到9.67亿美元，增幅超出预期。吉利德表示，其肝病产品组合的销售额增长10%，达到8.77亿美元，而细胞疗法产品的销售额则下降14%，至4.17亿美元，这反映出市场竞争加剧。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260804:nL4T4411XD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IBBQ","LU1571399168.USD","LU0965509010.AUD","MEDI","LU0965509101.SGD","IE00B19Z3B42.SGD","LU1585245621.USD","LU2112291526.USD","BK4588","LU1066053197.SGD","LU2089984988.USD","LU1934455277.USD","BBH","LU0823416689.USD","LU0965509283.SGD","LU0109394709.USD","TMED","SG9999015952.SGD","SG9999015986.USD","IE00B19Z3581.USD","IE00BSNM7G36.USD","LU0889565916.HKD","BMED","LU2468319806.SGD","SG9999015945.SGD","LU2324357040.USD","LU1037948897.HKD","SG9999015978.USD","LU1674673428.USD","BK4139","BIB","LU0114720955.EUR","TBXU","GILD","LU0882574055.USD","LU1061106388.HKD","BK4568","LU0965508806.USD","LU0289739699.SGD","BK4566","BK4583","BK4585","IBB","IE00B3T34201.USD","LU0234570918.USD","LU1066051498.USD","LU1778281490.HKD","IE00BZ1G4Q59.USD","LU0320765992.SGD","LU0058720904.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657568090","title":"前瞻：安進股價在財報公布前走高","url":"https://stock-news.laohu8.com/highlight/detail?id=2657568090","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657568090?lang=zh_tw&edition=fundamental","pubTime":"2026-08-05 01:30","pubTimestamp":1785864614,"startTime":"0","endTime":"0","summary":"BUZZ-前瞻：安进股价在财报公布前走高8月4日-** 安进AMGN.O股价周二上涨2.2%，该公司将于收盘后公布季度财报，投资者正密切关注其试验性减肥药的最新进展** 据伦敦证券交易所集团（LSEG）预测，这家生物技术公司预计将公布季度营收增长3%至94.2亿美元，而调整后每股收益则可能从6.02美元降至5.62美元** 在过去8个季度中，AMGN有7个季度达到了或超过了每股收益预期，最近一次未","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260804:nL4S4411RA:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1571399168.USD","LU0058720904.USD","IE00B2B36J28.USD","IE00BJT1NW94.SGD","BK4139","LU0122379950.USD","IE0009355771.USD","BK4534","IE00BJJMRZ35.SGD","LU0289739699.SGD","LU2089984988.USD","BK4581","BK4533","BK4566","BIB","IE0002141913.USD","BK4588","IE00BFTCPJ56.SGD","IBBQ","SG9999001440.SGD","BBH","LU2112291526.USD","LU1023059063.AUD","TBXU","LU2468319806.SGD","LU0109394709.USD","LU0868494617.USD","LU1983299246.USD","LU1061106388.HKD","LU1057294990.SGD","IE00B4R5TH58.HKD","PBE","BK4585","LU2242646821.SGD","LU0889565916.HKD","PJP","IBB","LU0320765992.SGD","BK4599","AMGN","LU2242652126.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1117517951","title":"Vertex 擴大領導團隊，為下一階段增長注入強勁動力","url":"https://stock-news.laohu8.com/highlight/detail?id=1117517951","media":"投资观察","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1117517951?lang=zh_tw&edition=fundamental","pubTime":"2026-08-04 20:02","pubTimestamp":1785844955,"startTime":"0","endTime":"0","summary":"宾夕法尼亚州普鲁士王，2026年8月4日——全球间接税与合规领域的“决策到防御”先锋，Vertex Inc.，今日宣布其领导团队迎来三位新成员，旨在为公司下一阶段的蓬勃发展提供坚实支撑。他们的加入，将通过对人才、区域运营及技术创新的领导力扩展，进一步强化 Vertex 的全球增长战略。在 Vertex，她将负责全球人才与企业文化战略，构建起推动业务规模化发展所需的人才储备和组织能力。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0823416689.USD","IE00BJJMRZ35.SGD","BK4604","LU2462157665.USD","BK4234","BK4585","IE00B894F039.SGD","GNMX","BK4084","LU1093756325.SGD","LU0079474960.USD","LU2324357040.USD","LU0757428866.USD","LU2089984988.USD","BK4532","LU0061475181.USD","BK4120","LU2456880835.USD","SG9999013999.USD","BK4099","BK4533","LU1815336091.USD","BIB","LU0109394709.USD","TISI","LU2362541273.HKD","SG9999001176.USD","BK4555","IE00BJT1NW94.SGD","LU0320765992.SGD","IE0002141913.USD","LU0417517546.SGD","LU1430594728.SGD","BK4023","TM","IE0009355771.USD","BK4567","LU1674673691.USD","LU2468319806.SGD","BBH","IBB","IDNA","03160","LU1778281490.HKD","VERX","PBE","LU2362540622.SGD","LU2417539215.USD","LU1069344957.HKD","BK4588","IE00B19Z9P08.USD","SGXZ57979304.SGD","IE0002270589.USD","VRTX","LU0889565916.HKD","LU0289739699.SGD","LU1093756168.USD","LU2236285917.USD","LU1559883803.SGD","LU1585245621.USD","LU0566484027.USD","IE00BFTCPJ56.SGD","IE00B2B36J28.USD","LU0432979614.USD","TBXU","LU1035775433.USD","LU2362541513.USD","LU1674673428.USD","LU0256863811.USD","IE00B19Z3B42.SGD","IBBQ","IE00B19Z9Z06.USD","IE00BZ9MQY76.HKD","SG9999001176.SGD","LU2237438978.USD","LU0234570918.USD","PW","LU0058720904.USD","BK4139","IE00B19Z3581.USD","IE00B4R5TH58.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1103561229","title":"重點關注個股：Palantir、SpaceX、滙豐控股","url":"https://stock-news.laohu8.com/highlight/detail?id=1103561229","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1103561229?lang=zh_tw&edition=fundamental","pubTime":"2026-08-04 17:28","pubTimestamp":1785835721,"startTime":"0","endTime":"0","summary":"**Palantir Technologies **：这家软件公司昨日盘后公布了强劲的财报，业绩表现亮眼，推动其盘前股价飙升逾15%。财报发布后，其股价微幅上涨。**汇丰控股 **：这家英国银行公布季度利润增长，并宣布了高达10亿美元的股票回购计划，但由于回购规模令部分投资者感到失望，其股价小幅走低。Segro股价小幅上扬，而安博盘前股价则基本持平。**辉瑞 、默沙东 、安进 与 BioNTech **：这些制药公司将在今日美股开盘前公布财报。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2860962120.EUR","DTRE","ERET","LU1852331112.SGD","BK4588","LU1989771016.USD","IE00B19Z9Z06.USD","IE00B894F039.SGD","LU1699723380.USD","LU1861215975.USD","SG9999015358.SGD","LU1093756325.SGD","LU1951198990.SGD","IE00BQXX3F31.USD","BK4605","LU0795875086.SGD","LU0979878070.USD","LU2355687059.USD","LU0211326839.USD","LU2362540622.SGD","LU0211326755.USD","SG9999002232.USD","BK4613","LU0225771236.USD","LU0198837287.USD","IE00BJTD4N35.SGD","IE00B1BXHZ80.USD","RWR","IE00BZ9MQY76.HKD","LU0124676726.USD","LU0719512351.SGD","LU2931357623.SGD","LU1242518857.USD","LU0889565916.HKD","LU0965508806.USD","LU1116320737.USD","LU2264538146.SGD","LU2250418816.HKD","RWO","LU0942090050.USD","LU2125909593.SGD","WISE","IE00BN8TJ469.HKD","LU0823421333.USD","DPRE","LU1585245621.USD","BMED","LU2458330243.SGD","LU1291159041.SGD","BK4521","JRE","AMUU","PAWZ","LU0122379950.USD","LU2125909247.SGD","LU1989764748.USD","LU0823434583.USD","LU0823416689.USD","IE0009355771.USD","LU2133065610.SGD","LU0642271901.SGD","PLOO","LU2896262040.SGD","LU0225284248.USD","LU0098860793.USD","LU2098885051.SGD","LU2106854487.HKD","LU0859254822.USD","SGXZ57979304.SGD","SPOG","SPCH","LU0238689110.USD","IE00BJTD4V19.USD","PLTG","IE00BMPRXN33.USD","LU2347655073.USD","LU0965509283.SGD","LU0980610538.SGD","LU2108987350.USD","LU2023250504.SGD","SG9999001176.USD","LU0889565833.HKD","AIS","EYES","IE00BSNM7G36.USD","LU0052756011.USD","ICF","LU2433249047.HKD","LU0792757196.USD","IE00BQXX3C00.GBP","LU0390134368.USD","LU1430594728.SGD","LU0432979614.USD","LU0795875169.SGD","TRUH","LU0689626769.HKD","WTRE","LU1023059063.AUD","LU2265009873.SGD","LU2290526834.HKD","IE00BJJMRX11.SGD","BK4554","CLIM","LU0211331839.USD","BK4571","BK4504","TBXU","PSI","SMHX","LU0823434740.USD","RNTY","SOXY","LU1803068979.SGD","FRI","BK4529","BK4534","PLTY","LU2468319806.SGD","LU0234572021.USD","LU1093756168.USD","SG9999013999.USD","OZEM","DFGR","LU0265550359.USD","AMYY","LU1861559042.SGD","IE00BFSS8Q28.SGD","LU1989764664.SGD","LU2360032135.SGD","BP.UK","LU1861220033.SGD","LU2236285917.USD","LU0130517989.USD","LU1267930813.SGD","LU0128525689.USD","AMDD","SG9999014567.USD","LU2089985449.USD","LU1894683264.USD","AMDW","BK4171","LU1066051498.USD","IE00BJJMRZ35.SGD","FREL","SG9999015341.SGD","LU1057294990.SGD","LU1066051811.HKD","PPH","PJP","LU1267930227.SGD","BK4604","BK4543","SCHH","LU1066051225.USD","BK4612","IE000M9KFDE8.USD","SMH","FTXH","LU0786609619.USD","LU1883839398.USD","WUGI","LU0868494617.USD","LU1804176565.USD","LU0106261372.USD","LU0081259029.USD","BK4550","IE00BMPRXR70.SGD","AMDL","DAMD","BK4568","LU0289739699.SGD","LU0861579265.USD","MCD","IE00B7KXQ091.USD","PLTR","LU0320765489.SGD","RITA","SPAX","BK4547","LU2361044949.HKD","ORBX","WSPC","LU0082616367.USD","SPCX","BK4581","LU1929549753.HKD","SPOT","IE00BLSP4452.SGD","JPRE","LU0320765646.SGD","LU1232071149.USD","LU2361044865.SGD","LU1923623000.USD","LU1201861249.SGD","IE0002141913.USD","USRT","LU1303367103.USD","PFE","LU0456855351.SGD","LU1066053197.SGD","LU2023250843.SGD","LU2357627491.SGD","BBH","BK4575","LU2125154778.USD","IYR","LU0985320562.USD","BK4141","TRFK","IETC","LU1037948541.HKD","BK4566","HSBC","IE00B2B36J28.USD","IE00BQXX3D17.EUR","LU1732800096.USD","XNTK","LU1244550221.USD","BK4592","LU1035773651.USD","SPCG","AMGN","LU1989772840.SGD","PLTA","BK4535","AMDU","03160","IGV","IBB","IE00BJJMRY28.SGD","LU1894683348.USD","IE00BFTCPJ56.SGD","AVRE","LU1316542783.SGD","BNTX","GUNZ","PLTZ","IE00BKVL7J92.USD","BIB","VGSR","BK4599","HRTS","LU0726765562.USD","CRED","LU0889566641.SGD","LU2125154935.USD","LU2362541273.HKD","CNAV","SG9999003800.SGD","LU0868494708.USD","04332","LU1989772923.USD","BK4512","IE00B19Z3B42.SGD","LU2242652126.USD","LU2242646821.SGD","LU0310800965.SGD","PLD","FTXL","BAI","BK4224","LU1244550577.SGD","SSPC","IE0001KFT4U8.USD","FHLC","LU0321505439.SGD","LU1974910355.USD","IE00BJT1NW94.SGD","CHAT","PLTW","BK4610","LU0306806265.USD","SHLD","LU0109394709.USD","LU0256863811.USD","LU0048584097.USD","LU1061106388.HKD","00005","LU0985481810.HKD","LU1064131342.USD","IE00BMPRXQ63.HKD","LU0203345920.USD","LU2324357040.USD","LU2491049909.HKD","BK4614","IE00B19Z9P08.USD","LU0127658192.USD","SGXZ51526630.SGD","WARP","LU1934455194.USD","LU1732799900.SGD","LU0274383776.USD","BK4007","IE00B19Z3581.USD","LU1941712348.USD","MARS","CHPS","PPTY","IE00B3T34201.USD","LU2491050071.SGD","IE0002270589.USD","BK4548","LU2247934214.USD","LU0109392836.USD","LU2462591350.SGD","XLRE","LU0306807586.USD","LU2347655156.SGD","GDOC","LU0417517546.SGD","BK4139","BK4532","LU2491050154.USD","LU1242518931.SGD","PSR","LU1037948897.HKD","IE00B4R5TH58.HKD","LU0976567544.SGD","SPCF","SG9999011175.SGD","LU1861558580.USD","LU2054465674.USD","PLTI","LU0174119429.USD","AIQ","BK4207","LU1934455277.USD","SPRE","IE0004445015.USD","AMD","IBBQ","TM","LU2362541513.USD","AMDG","LU2360107168.USD","BBRE","IHE","LU2461242641.AUD","LU1069347547.HKD","REIT","LU0056508442.USD","BK4209","LU0208291251.USD","LU0251132253.USD","SPCM","LU2361045086.USD","BK4551","LU1718418525.SGD","GQRE","SG9999001424.SGD","LU0266013472.USD","LU1074936037.SGD","XLV","IE00BLSP4239.USD","JDOC","LU2458330169.SGD","LU1941712264.USD","VHT","BK4567","BK4573","BK4516","IE0004445239.USD","LU0006306889.USD","LU0965509010.AUD","PBE","LOFF","SOXX","IYRI","SG9999014575.USD","LU1116320901.HKD","LU0965509101.SGD","LU1244550494.USD","LU2089984988.USD","URE","LU0203347892.USD","SG9999002224.SGD","PLTD","LU2112291526.USD","DFAR","TRUR","LU0321505868.SGD","IE00BZ1G4Q59.USD","BK4559","AMDS","BK4108","LU1951200564.SGD","SG9999001440.SGD","AIPI","LU0070302665.USD","IXJ","LU2242649171.HKD","GAMR","MRK","LU1923622614.USD","LU0320765992.SGD","LU0912757837.SGD","LU0265550946.USD","LU1880398554.USD","BK4099","BK4533","PTIR","LU1917777945.USD","PLYY","SGXZ99366536.SGD","SPCQ","LU0648001328.SGD","IYH","SG9999014559.SGD","REET","LU1162221912.USD","ARTY","IE00B5949003.HKD","HSBH","LU2360106780.USD","BK4555","LEGR","SG9999001176.SGD","LU0170899867.USD","LU0058720904.USD","USXF","LU0133085943.USD","RXL","PLT","PLTU","TTEQ","INDS","LU2279689827.SGD","QQQA","TEK","LU2596442595.SGD","AMDY","LU0130102774.USD","LU1571399168.USD","SGXZ81514606.USD","BK4089","LU0496365809.HKD","SG9999014542.SGD","FAI","IE0009356076.USD","LU1983260115.SGD","IE00BFSS7M15.SGD","LU0210536198.USD","LU0823421416.USD","BK4023","LU0477156953.USD","LU1880398471.USD","VNQ","BK4585","LU1988902786.USD","ILDR","IE00BBT3K403.USD","LU1983299246.USD","LU1934455863.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656539622","title":"非阿片止痛藥新鋭Latigo(LTGO.US)IPO擬最高募資2.88億美元，Nav1.8抑制劑劍指福泰製藥(VRTX.US)百億市場","url":"https://stock-news.laohu8.com/highlight/detail?id=2656539622","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656539622?lang=zh_tw&edition=fundamental","pubTime":"2026-08-04 16:59","pubTimestamp":1785833974,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BIB","LU2468319806.SGD","GNMX","KCE","TBXU","LU0256863811.USD","VRTX","IE00B19Z3581.USD","IBB","PBE","LU0417517546.SGD","LU1674673428.USD","BK4532","LU2456880835.USD","IE0002141913.USD","LU0234570918.USD","BK4127","LU1093756168.USD","IE00BFTCPJ56.SGD","IE00BJT1NW94.SGD","IE00BJJMRZ35.SGD","IDNA","LU0058720904.USD","LU1093756325.SGD","SGXZ57979304.SGD","IE00B4R5TH58.HKD","BK4585","IBBQ","IE00BZ9MQY76.HKD","LTGO","LU2324357040.USD","BK4588","LU2362541273.HKD","LU1430594728.SGD","LU1585245621.USD","BK4533","BBH","LU0823416689.USD","LU0889565916.HKD","LU1778281490.HKD","REDS","LU2362541513.USD","SG9999013999.USD","LU0289739699.SGD","IPOS","FRHC","IE00B19Z9Z06.USD","BK4139","IE00B19Z3B42.SGD","IE00B19Z9P08.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1126575276","title":"福泰製藥重申2026年全年指引：GAAP與非GAAP研發、AI研發及銷售管理費用預期不變","url":"https://stock-news.laohu8.com/highlight/detail?id=1126575276","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1126575276?lang=zh_tw&edition=fundamental","pubTime":"2026-08-04 04:07","pubTimestamp":1785787669,"startTime":"0","endTime":"0","summary":"福泰制药（Vertex Pharmaceuticals）再次确认其2026年全年财务指引。在涵盖GAAP及非GAAP口径下的研发支出、AI研发投入以及销售、一般及管理费用（SG&A）方面，该公司均维持此前预期不变，未作出任何调整。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2236285917.USD","LU0320765992.SGD","LU2324357040.USD","LU2456880835.USD","LU1674673691.USD","LU1674673428.USD","LU2417539215.USD","BK4567","LU0058720904.USD","SG9999001176.SGD","IE00B19Z3581.USD","IE0002141913.USD","IE00B4R5TH58.HKD","LU1585245621.USD","IBBQ","LU1778281490.HKD","LU2468319806.SGD","IE00BZ9MQY76.HKD","LU0079474960.USD","LU1430594728.SGD","BK4585","LU2462157665.USD","LU0061475181.USD","BK4588","IE0009355771.USD","LU0289739699.SGD","LU1069344957.HKD","LU2362540622.SGD","LU0889565916.HKD","IE00B19Z9P08.USD","IDNA","BK4533","LU0823416689.USD","LU1093756168.USD","LU2362541513.USD","VRTX","IE00BJJMRZ35.SGD","LU0432979614.USD","PBE","IE00B894F039.SGD","LU2089984988.USD","BK4532","LU0417517546.SGD","SGXZ57979304.SGD","TBXU","BBH","IE00B19Z9Z06.USD","LU1035775433.USD","BK4139","LU2237438978.USD","IBB","IE00BJT1NW94.SGD","LU2362541273.HKD","IE00B19Z3B42.SGD","SG9999013999.USD","LU1093756325.SGD","LU0234570918.USD","GNMX","LU0256863811.USD","IE00BFTCPJ56.SGD","BIB","IE00B2B36J28.USD","SG9999001176.USD","IE0002270589.USD","LU0109394709.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1141963964","title":"福泰製藥：基於現行關税法規，2026年指引中關税成本影響依然微乎其微","url":"https://stock-news.laohu8.com/highlight/detail?id=1141963964","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1141963964?lang=zh_tw&edition=fundamental","pubTime":"2026-08-04 04:04","pubTimestamp":1785787449,"startTime":"0","endTime":"0","summary":"福泰制药（Vertex Pharmaceuticals）表示，根据当前已知的关税税率与相关法规，其2026年业绩指引中继续纳入的关税成本影响，仍属微不足道。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IBBQ","SG9999001176.USD","IE0002141913.USD","LU2236285917.USD","BK4533","IE00BJT1NW94.SGD","LU1674673691.USD","SG9999013999.USD","LU2456880835.USD","SGXZ57979304.SGD","LU2362541513.USD","LU1035775433.USD","LU0432979614.USD","IE00B19Z9Z06.USD","IE00B19Z3B42.SGD","IE00B894F039.SGD","LU1585245621.USD","BK4532","IDNA","SG9999001176.SGD","BK4588","LU1430594728.SGD","LU1069344957.HKD","LU2089984988.USD","PBE","LU2237438978.USD","BBH","LU0823416689.USD","LU0109394709.USD","LU1093756168.USD","IE00BJJMRZ35.SGD","LU1093756325.SGD","IE00B19Z3581.USD","IE0002270589.USD","LU2417539215.USD","LU2462157665.USD","LU0889565916.HKD","VRTX","LU2468319806.SGD","BK4567","LU2324357040.USD","IE00BFTCPJ56.SGD","GNMX","IE00B19Z9P08.USD","IE00B4R5TH58.HKD","LU1674673428.USD","BK4139","BIB","TBXU","LU0061475181.USD","LU2362541273.HKD","LU0256863811.USD","IE0009355771.USD","LU0289739699.SGD","LU0234570918.USD","IBB","BK4585","LU2362540622.SGD","IE00BZ9MQY76.HKD","LU0417517546.SGD","LU1778281490.HKD","LU0079474960.USD","LU0320765992.SGD","IE00B2B36J28.USD","LU0058720904.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656630972","title":"Vertex憑藉囊性纖維化藥物的強勁表現上調年度營收預期","url":"https://stock-news.laohu8.com/highlight/detail?id=2656630972","media":"路透中文","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656630972?lang=zh_tw&edition=fundamental","pubTime":"2026-08-04 04:02","pubTimestamp":1785787378,"startTime":"0","endTime":"0","summary":"Vertex凭借囊性纤维化药物的强劲表现上调年度营收预期路透8月3日-Vertex Pharmaceuticals周一上调了年度营收预期的上限，此举得益于其囊性纤维化治疗药物需求的强劲增长。Vertex表示，其年度展望未包含待完成的Crinetics收购交易，待交易于第三季度完成后，将提供更新后的预测。该公司表示，这一增长主要得益于囊性纤维化疗法的持续良好表现。Vertex报告称，经调整后的季度每股收益为4.73美元，符合市场预期。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260803:nL4T4401T9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TBXU","IE00B894F039.SGD","BBH","LU1035775433.USD","LU0417517546.SGD","LU2324357040.USD","IBB","LU2362541513.USD","IE00B4R5TH58.HKD","LU2468319806.SGD","BK4567","GNMX","BK4532","LU0256863811.USD","LU1093756325.SGD","LU2417539215.USD","IBBQ","IE0002270589.USD","LU1430594728.SGD","LU1674673428.USD","LU0234570918.USD","LU1778281490.HKD","LU0289739699.SGD","LU1069344957.HKD","LU2362541273.HKD","IE00B19Z9P08.USD","PBE","IE00BFTCPJ56.SGD","IE0009355771.USD","IE0002141913.USD","LU1585245621.USD","IE00BJJMRZ35.SGD","SG9999013999.USD","VRTX","CRNX","LU2362540622.SGD","IE00B2B36J28.USD","IDNA","IE00BZ9MQY76.HKD","LU0432979614.USD","IE00BJT1NW94.SGD","SG9999001176.USD","SGXZ57979304.SGD","IE00B19Z3B42.SGD","BIB","LU0320765992.SGD","BK4007","LU0079474960.USD","SG9999001176.SGD","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656031243","title":"加州最高法院在「創新義務」案中裁定吉利德勝訴","url":"https://stock-news.laohu8.com/highlight/detail?id=2656031243","media":"路透中文","labels":["policyRegulatory","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656031243?lang=zh_tw&edition=fundamental","pubTime":"2026-08-04 01:02","pubTimestamp":1785776562,"startTime":"0","endTime":"0","summary":"加州最高法院在“创新义务”案中裁定吉利德胜诉路透8月3日-加利福尼亚州最高法院周一就一起案件作出裁决，支持吉利德科学公司GILD.O，该案涉及被视为安全的药物制造商是否必须尝试开发更安全的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260803:nL4T4401N8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"加州最高法院在“创新义务”案中裁定吉利德胜诉","news_tag":"policyRegulatory,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BMED","LU1585245621.USD","LU0289739699.SGD","BK4566","LU1037948897.HKD","BK4578","IE00BSNM7G36.USD","LU1934455194.USD","IBB","BK4585","LU0965509283.SGD","TBXU","LU1037948541.HKD","LU1839511570.USD","LU0823416689.USD","BK4139","LU2324357040.USD","LU1674673691.USD","GILD","BK4588","SG9999015945.SGD","BK4532","LU0058720904.USD","LU2112291526.USD","LU1066051498.USD","BK4568","IE00B19Z3581.USD","LU1571399168.USD","IE00B7SZLL34.SGD","LU0965509010.AUD","BBH","IE00B3T34201.USD","LU0861579265.USD","LU0882574055.USD","IE00BKVL7J92.USD","LU1674673428.USD","LU1023059063.AUD","LU2089984988.USD","BIB","IE00BZ1G4Q59.USD","MEDI","IE00B19Z3B42.SGD","LU1778281490.HKD","IBBQ","LU1057294990.SGD","LU0122379950.USD","TMED","LU0965508806.USD","IE0002270589.USD","LU0965509101.SGD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":8,"pageCount":4,"totalSize":150,"code":"91000000","status":"200"}]}}